IDEAS home Printed from https://ideas.repec.org/r/eee/respol/v39y2010i6p810-821.html

Knowledge sources, patent protection, and commercialization of pharmaceutical innovations

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Ugo Finardi, 2013. "The technological paradigm of Nanosciences and Technologies: a study of science-technology time and space relations," Economía: teoría y práctica, Universidad Autónoma Metropolitana, México, vol. 39(2), pages 11-29, Julio-Dic.
  2. Chang, Ching-Wen & Yamanaka, Takayuki & Kano, Shingo, 2019. "An enforced loop-out knowledge flow facilitates industry competition: Learning from the pharmaceutical and genetically modified seed industries," Technovation, Elsevier, vol. 79(C), pages 11-24.
  3. Andrea Bastianin & Paolo Castelnovo & Massimo Florio & Anna Giunta, 2019. "Technological Learning and Innovation Gestation Lags at the Frontier of Science: from CERN Procurement to Patent," Papers 1905.09552, arXiv.org.
  4. Moaniba, Igam M. & Lee, Pei-Chun & Su, Hsin-Ning, 2020. "How does external knowledge sourcing enhance product development? Evidence from drug commercialization," Technology in Society, Elsevier, vol. 63(C).
  5. Darlenis Herrera-Vallejera & Salvador Gorbea-Portal, 2021. "Pharmacology and Pharmacy: research and innovation analysis," Scientometrics, Springer;Akadémiai Kiadó, vol. 126(3), pages 2513-2522, March.
  6. Sternitzke, Christian, 2013. "An exploratory analysis of patent fencing in pharmaceuticals: The case of PDE5 inhibitors," Research Policy, Elsevier, vol. 42(2), pages 542-551.
  7. Natália Barbosa & Ana Paula Faria & Vasco Eiriz, 2014. "Industry- and firm-specific factors of innovation novelty," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 23(3), pages 865-902.
  8. Miozzo, Marcela & DiVito, Lori, 2016. "Growing fast or slow?: Understanding the variety of paths and the speed of early growth of entrepreneurial science-based firms," Research Policy, Elsevier, vol. 45(5), pages 964-986.
  9. Wang, Xuefeng & Zhang, Shuo & Liu, Yuqin & Du, Jian & Huang, Heng, 2021. "How pharmaceutical innovation evolves: The path from science to technological development to marketable drugs," Technological Forecasting and Social Change, Elsevier, vol. 167(C).
  10. Roberto Camerani & Daniele Rotolo & Nicola Grassano, 2018. "Do firms publish? A multi-sectoral analysis," JRC Working Papers on Corporate R&D and Innovation 2018-05, Joint Research Centre.
  11. Igor Rosa Dias Jesus & Helder Gomes Costa, 2015. "Interfaces between production engineering and the public affairs: evidences from bibliometric analysis," Scientometrics, Springer;Akadémiai Kiadó, vol. 105(2), pages 1183-1193, November.
  12. Guderian, Carsten C. & Posth, Jan-Alexander & Grob, Linus, 2023. "Investment decisions and passive portfolio construction utilizing patent analytics: A multi-case study on COVID-19 treatment technologies," The Quarterly Review of Economics and Finance, Elsevier, vol. 92(C), pages 66-87.
  13. Ingo Stiller & Arjen Witteloostuijn & Bart Cambré, 2022. "Determinants of radical drug innovation: a systematic literature review," Management Review Quarterly, Springer, vol. 72(4), pages 967-1016, December.
  14. Anckaert, Paul-Emmanuel, 2025. "When the drugs (don’t) work: The role of science in product commercialization," Research Policy, Elsevier, vol. 54(5).
  15. Caviggioli, Federico & De Marco, Antonio & Montobbio, Fabio & Ughetto, Elisa, 2020. "The licensing and selling of inventions by US universities," Technological Forecasting and Social Change, Elsevier, vol. 159(C).
  16. Qingjun Zhao & Jiancheng Guan, 2013. "Love dynamics between science and technology: some evidences in nanoscience and nanotechnology," Scientometrics, Springer;Akadémiai Kiadó, vol. 94(1), pages 113-132, January.
  17. Mammadaliyev, Farid & Gilsing, Victor & Knoben, J., 2024. "How do firms adapt their portfolios of external collaborations to changing internal organizational attributes? The moderating role of firm age," Other publications TiSEM 56c854b7-ed86-4830-843e-c, Tilburg University, School of Economics and Management.
  18. Guijie Zhang & Yuqiang Feng & Guang Yu & Luning Liu & Yanqiqi Hao, 2017. "Analyzing the time delay between scientific research and technology patents based on the citation distribution model," Scientometrics, Springer;Akadémiai Kiadó, vol. 111(3), pages 1287-1306, June.
  19. Jie Wu & Kathryn Rudie Harrigan & Siah Hwee Ang & Zefu Wu, 2019. "The impact of imitation strategy and R&D resources on incremental and radical innovation: evidence from Chinese manufacturing firms," The Journal of Technology Transfer, Springer, vol. 44(1), pages 210-230, February.
  20. Lorenzo Ardito & Roger Svensson, 2024. "Sourcing applied and basic knowledge for innovation and commercialization success," The Journal of Technology Transfer, Springer, vol. 49(3), pages 959-995, June.
  21. Rotolo, Daniele & Camerani, Roberto & Grassano, Nicola & Martin, Ben R., 2022. "Why do firms publish? A systematic literature review and a conceptual framework," Research Policy, Elsevier, vol. 51(10).
  22. Rahul RK Kapoor & Nicolas van Zeebroeck, 2016. "The laws of action and reaction: on determinants of patent disputes in European chemical and drug industries," Working Papers TIMES² WP 2016-019, ULB -- Universite Libre de Bruxelles.
  23. Sampat, Bhaven N. & Shadlen, Kenneth C., 2017. "Secondary pharmaceutical patenting: A global perspective," Research Policy, Elsevier, vol. 46(3), pages 693-707.
  24. Ardito, Lorenzo & Miroshnychenko, Ivan & Messeni Petruzzelli, Antonio & De Massis, Alfredo, 2025. "Family CEO and radical innovation: A stewardship perspective," Research Policy, Elsevier, vol. 54(1).
  25. Byrski, Dennis & Wang, Lucy Xiaolu, 2025. "Marketing authorization and strategic patenting: Evidence from pharmaceuticals," Journal of Public Economics, Elsevier, vol. 247(C).
  26. Xue Yang & Hao Zhang & Die Hu & Bingde Wu, 2023. "The timing dilemma: understanding the determinants of innovative startups’ patent collateralization for loans," Small Business Economics, Springer, vol. 60(1), pages 371-403, January.
  27. Wang, Fang, 2024. "Does the recombination of distant scientific knowledge generate valuable inventions? An analysis of pharmaceutical patents," Technovation, Elsevier, vol. 130(C).
  28. Gao, Yang & Liu, Siqiang & Yang, Lu, 2025. "Artificial intelligence and innovation capability: A dynamic capabilities perspective," International Review of Economics & Finance, Elsevier, vol. 98(C).
  29. Yoon, Jeeyoung & Syafiandini, Arida Ferti & Song, Min, 2023. "Exploring the knowledge certainty shift: Metaknowledge analysis on drugs via assertion uncertainty burstiness," Journal of Informetrics, Elsevier, vol. 17(2).
  30. Gianluca Fabiano & Andrea Marcellusi & Giampiero Favato, 2020. "Public–private contribution to biopharmaceutical discoveries: a bibliometric analysis of biomedical research in UK," Scientometrics, Springer;Akadémiai Kiadó, vol. 124(1), pages 153-168, July.
  31. Shang, Qingyan & Poon, Jessie P.H. & Yue, Qingtang, 2012. "The role of regional knowledge spillovers on China's innovation," China Economic Review, Elsevier, vol. 23(4), pages 1164-1175.
  32. Ingo Stiller & Arjen Witteloostuijn & Bart Cambré, 2021. "Do current radical innovation measures actually measure radical drug innovation?," Scientometrics, Springer;Akadémiai Kiadó, vol. 126(2), pages 1049-1078, February.
  33. Dai, Rong & Watal, Jayashree, 2021. "Product patents and access to innovative medicines," Social Science & Medicine, Elsevier, vol. 291(C).
  34. Anna Giunta & Filippo M. Pericoli & Eleonora Pierucci, 2016. "University–Industry collaboration in the biopharmaceuticals: the Italian case," The Journal of Technology Transfer, Springer, vol. 41(4), pages 818-840, August.
  35. Giovanni Cerulli & Giovanni Marin & Eleonora Pierucci & Bianca Potì, 2022. "Do company-owned academic patents influence firm performance? Evidence from the Italian industry," The Journal of Technology Transfer, Springer, vol. 47(1), pages 242-269, February.
  36. Yang, Guancan & Lu, Guoxuan & Xu, Shuo & Chen, Liang & Wen, Yuxin, 2023. "Which type of dynamic indicators should be preferred to predict patent commercial potential?," Technological Forecasting and Social Change, Elsevier, vol. 193(C).
  37. Sommer, Daniel & Bhandari, Krishna Raj, 2022. "Internationalization of R&D and Innovation Performance in the Pharma Industry," Journal of International Management, Elsevier, vol. 28(3).
  38. Amel Attour & Pierre Barbaroux, 2016. "The Role of Knowledge Processes in a Business Ecosystem's Lifecycle," Post-Print hal-03223699, HAL.
  39. Eleonora Pierucci, 2015. "University-industry linkages. Among italian regions: a supply-demand analysis," RIVISTA DI ECONOMIA E STATISTICA DEL TERRITORIO, FrancoAngeli Editore, vol. 2015(2), pages 5-33.
  40. Wagner, Stefan & Wakeman, Simon, 2016. "What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry," Research Policy, Elsevier, vol. 45(5), pages 1091-1102.
  41. Salandra, Rossella, 2018. "Knowledge dissemination in clinical trials: Exploring influences of institutional support and type of innovation on selective reporting," Research Policy, Elsevier, vol. 47(7), pages 1215-1228.
  42. Claudimar Pereira da Veiga & Cassia Rita Pereira da Veiga & Mônica Maier Giacomini & Heitor Takashi Kato & Jansen Maia Del Corso, 2015. "Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market," International Review of Management and Marketing, Econjournals, vol. 5(3), pages 141-153.
  43. Puccetti, Giovanni & Giordano, Vito & Spada, Irene & Chiarello, Filippo & Fantoni, Gualtiero, 2023. "Technology identification from patent texts: A novel named entity recognition method," Technological Forecasting and Social Change, Elsevier, vol. 186(PB).
  44. Zhao, Shengchao & Zeng, Deming & Li, Jian & Feng, Ke & Wang, Yao, 2023. "Quantity or quality: The roles of technology and science convergence on firm innovation performance," Technovation, Elsevier, vol. 126(C).
  45. Amel Attour & Pierre Barbaroux, 2021. "The Role of Knowledge Processes in a Business Ecosystem’s Lifecycle," Journal of the Knowledge Economy, Springer;Portland International Center for Management of Engineering and Technology (PICMET), vol. 12(1), pages 238-255, March.
  46. Andrea Bastianin & Paolo Castelnovo & Massimo Florio & Anna Giunta, 2022. "Big science and innovation: gestation lag from procurement to patents for CERN suppliers," The Journal of Technology Transfer, Springer, vol. 47(2), pages 531-555, April.
  47. Du, Jian & Li, Peixin & Guo, Qianying & Tang, Xiaoli, 2019. "Measuring the knowledge translation and convergence in pharmaceutical innovation by funding-science-technology-innovation linkages analysis," Journal of Informetrics, Elsevier, vol. 13(1), pages 132-148.
  48. Bonnin Roca, Jaime & O'Sullivan, Eoin, 2022. "The role of regulators in mitigating uncertainty within the Valley of Death," Technovation, Elsevier, vol. 109(C).
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.